NECTAR LIFESCIENCES LTD.
BSE: 532649
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.00-100.0% | 5.00-98.2% | 280.67-34.8% | 430.69-5.3% | 454.98+6.3% | 428.10 |
| Other Income | 0.66-10.8% | 0.74+111.7% | 0.35+350.3% | 0.08-86.4% | 0.57-16.8% | 0.69 |
| Total Income | 0.66-88.5% | 5.74-98.0% | 281.02-34.8% | 430.77-5.4% | 455.56+6.2% | 428.79 |
| EXPENSES | ||||||
| Expenditure | 32.21+415.9% | 6.24-98.3% | 377.78-38.9% | 618.44+39.6% | 443.01+5.4% | 420.12 |
| Tax | 11.03+6332.3% | -0.18+99.5% | -33.52+41.8% | -57.58-1323.2% | 4.71+53.5% | 3.07 |
| PROFIT | ||||||
| PBT | 56.60+11281.5% | -0.51+99.5% | -96.75+48.4% | -187.66-1595.6% | 12.55+44.8% | 8.67 |
| Net Profit | 14.27+108.1% | -176.01-178.4% | -63.23+51.4% | -130.09-1759.3% | 7.84+40.0% | 5.60 |
| KEY METRICS | ||||||
| OPM % | — | -20.87%+1.18pp | -22.05%+13.78pp | -35.83%-31.27pp | -4.56%+1.84pp | -6.40% |
| NPM % | 100.00%+200.00pp | -100.00%-77.50pp | -22.50%+7.70pp | -30.20%-31.92pp | 1.72%+0.41pp | 1.31% |
| EPS | 3.02+30100.0% | 0.01-99.6% | 2.82-51.4% | 5.80+1557.1% | 0.35+40.0% | 0.25 |
Corporate Events
Board MeetingNECLIFE
202630May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingNECLIFE
20257Jul
Board Meeting
Transfer of the active pharmaceutical ingredients and formul…
BSE Filing ↗ Board MeetingNECLIFE
202414Feb
Board Meeting
Consider and approve Financial Results for the quarter and n…
BSE Filing ↗ Board MeetingNECLIFE
202310Nov
Board Meeting
Consider and approve financial Results for the quarter and h…
BSE Filing ↗ Board MeetingNECLIFE
202314Aug
Board Meeting
Consider and approve the financial results for the period en…
BSE Filing ↗